The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
An De Vriese, MD, PhD
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD
Jörg Latus, MD
The Evolving Role of Biomarkers in IgAN
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Itching for Answers: Holistic CKD-aP Care
Gabapentinoids: Safety Considerations and Downstream Outcomes
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
When Itching Hurts: Quality of Life Disruption in CKD-aP
Winning the CKD-aP Battle: A United Physician-Nurse Front
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Claudia Seikrit, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.